menu
    • menu

    Company profile for RNAimmune

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RNAimmune is a leading company in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of RNAimmune's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the develo...
    RNAimmune is a leading company in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of RNAimmune's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RNAimmuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    401 Professional Drive #280 Gaithersburg, MD 20879
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rnaimmune.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RNAimmune Receives Investigational NDA Clearance from U.S. FDA for RV-1770
    RNAimmune Receives Investigational NDA Clearance from U.S. FDA for RV-1770

    18 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rnaimmune-receives-investigational-new-drug-application-clearance-from-us-fda-for-mrna-based-respiratory-syncytial-virus-vaccine-rv-1770-302017866.html

    PR NEWSWIRE
    18 Dec 2023
    Share Share
    FDA Approves Drug Product Filled with Berkshire Sterile’s Low Loss Fill Process
    FDA Approves Drug Product Filled with Berkshire Sterile’s Low Loss Fill Process

    19 May 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-05-19/fda-approves-drug-product-filled-with-berkshire-steriles-low-loss-fill-process/?widget=listSection

    CONTRACT PHARMA
    19 May 2023
    Share Share
    RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at AACR
    RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at AACR

    07 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rnaimmune-mrna-cancer-vaccine-program-accepted-for-oral-presentation-at-the-2023-aacr-annual-meeting-301740412.html

    PR NEWSWIRE
    07 Feb 2023
    Share Share
    RNAimmune Secures $27M Series A Round of Financing
    RNAimmune Secures $27M Series A Round of Financing

    29 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/rnaimmune-secures-27-million-series-a-round-of-financing-for-development-of-mrna-therapeutics-and-vaccines-301513350.html

    PRNEWSWIRE
    29 Mar 2022
    Share Share
    Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
    Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.

    13 Oct 2020

    // BIOSPACE

    https://www.biospace.com/article/nestle-announces-results-of-tender-offer-for-aimmune-therapeutics-inc-/?s=79

    BIOSPACE
    13 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search